Results of the ISAR-LEFT MAIN 2 trial presented at TCT 2012

Second generation drug-eluting stents are safe and effective in treatment of left main coronary artery disease

2012-10-25

(Press-News.org) MIAMI, FL – OCTOBER 24, 2012 – A study found that second-generation drug-eluting stents are safe and effective in the treatment of left main coronary artery lesions. Results of the ISAR-LEFT MAIN 2 trial were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.

Patients undergoing invasive treatment of unprotected left main coronary artery (uLMCA) lesions are often considered at high-risk of adverse cardiovascular events. The use of first generation drug-eluting stents in these lesions has previously been shown to be feasible, safe, and effective. The second-generation zotarolimus-eluting (ZES) and everolimus-eluting stents (EES), used more widely in clinical practice at present, perform very similarly in nearly all coronary artery lesions. However, their performance in uLMCA lesions has not yet been assessed.

The ISAR-LEFT MAIN 2 trial is the first and largest performed randomized, multicenter comparison trial between ZES and EES in uLMCA lesions. The study was designed to assess the non-inferiority of ZES to EES regarding the primary end-point: incidence of major adverse cardiac events (MACE), which was defined as the composite of death, myocardial infarction or target lesion revascularization at one-year follow-up. Secondary endpoints included the incidence of definite/probable stent thrombosis at one-year follow-up and angiographic restenosis at six-nine month follow-up.

In total, 650 patients with ischemic symptoms or evidence of myocardial ischemia in the presence of at least one ≥ 50 percent de novo stenosis located in the LMCA who were unable or unwilling to undergo surgery were randomly assigned to receive ZES (n= 324) or EES (n=326).

The incidence of MACE was 17.5 percent in the ZES group and 14.3 percent in the EES group (p=0.25). The incidence of definite stent thrombosis was 0.6 percent in both groups, while probable stent thrombosis occurred in 0.3 percent of the ZES group and 0 percent of the EES group. Angiographic restenosis occurred in 21.5 percent of the ZES group and 16.8 percent of the EES group.

"Results of this trial indicate that the use of second generation drug-eluting stents in unprotected left main coronary artery lesions in relatively unselected patients is feasible, safe and effective," said lead investigator, Julinda Mehilli, MD. Prof. Dr. Mehilli is Director of Catheterization Laboratories at the Medizinische Klinik I, Klinikum der Universitaet Munich and Co-Director of Clinical Research and Data Coordinating in the Intracoronary Stenting and Antithrombosis Research (ISAR) Center at the German Heart Center in Munich.

"Both zotarolimus and everolimus stents provide similar clinical and angiographic outcomes at one-year follow-up in this high-risk patient population," said Dr. Mehilli.

The results of the ISAR-LEFT MAIN 2 trial will be presented on Wednesday, October 24 at 11:58 AM in the Main Arena (Hall D) of the Miami Beach Convention Center.

### The trial was an investigator initiated trial without any industry funding. Dr. Mehilli reported receiving lecture fees from Lilly/Daiichi Sankyo, Abbott Vascular and Terumo.

About CRF The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine.

Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of the Cardiovascular Research Foundation. TCT gathers leading medical researchers and clinicians from around the world to present and discuss the latest developments in the field.

For more information, visit www.crf.org. END

ELSE PRESS RELEASES FROM THIS DATE:

Scientists target bacterial transfer of resistance genes

2012-10-25

CHAMPAIGN, Ill. — The bacterium Streptococcus pneumoniae – which can cause pneumonia, meningitis, bacteremia and sepsis – likes to share its antibiotic-defeating weaponry with its neighbors. Individual cells can pass resistance genes to one another through a process called horizontal gene transfer, or by "transformation," the uptake of DNA from the environment. Now researchers report that they can interrupt the cascade of cellular events that allows S. pneumoniae to swap or suck up DNA. The new findings, reported in the journal PLoS ONE, advance the effort to develop ...

Research findings breathe new life into lung disease

2012-10-25

TORONTO, Oct. 24, 2012--It turns out the muscle cells on the outside of blood vessels have been wrongly accused for instigating lung disease. New research shows that while these muscle cells are responsible for constricting or dilating the blood vessels, they are not responsible for sensing the amount of oxygen that gets to the lungs. That message comes from the endothelial cells – special cells that line the blood vessels – along a "signalling pathway." When a person is low on oxygen, blood vessels throughout the body expand to improve the delivery of this vital molecule ...

Is obesity irreversible? Timing is key in weight loss, U-M research shows

2012-10-25

ANN ARBOR, Mich. — Joint research between the University of Michigan and the Argentina-based National Council of Science and Technology (CONICET) has shed light on one of the most frustrating mysteries of weight loss – why the weight inevitably comes back. A novel animal model showed that the longer mice remained overweight, the more "irreversible" obesity became, according to the new study that appeared online ahead of print Oct.24 in the Journal of Clinical Investigation. Over time, the static, obese state of the mice reset the "normal," body weight set point to ...

Mesh-covered stent helps restoration of blood flow in heart attack patients undergoing PCI

2012-10-25

MIAMI, FL – OCTOBER 24, 2012 – A clinical trial found that the use of a next generation, micronet, mesh-covered stent demonstrated improved restoration of blood flow to heart tissue, compared to the use of either bare-metal or drug-eluting stents in heart attack patients undergoing angioplasty. Results of the MASTER trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium and will appear in the November 6th issue of the Journal of the American College of Cardiology. Sponsored by the Cardiovascular Research Foundation, ...

Knee replacement not an 'easy solution' for obese patients

2012-10-25

ROSEMONT, IL–Obese patients have a greater risk of complications following total knee replacement surgery, including post-surgical infections, according to a new literature review recently published in the Journal of Bone and Joint Surgery (JBJS). Because of complications, obese patients are more likely to require follow-up surgery (revision). Obesity is reaching epidemic proportions, particularly in the United States, and is a well-documented risk factor for the development of osteoarthritis. Arthritis is initially treated nonsurgically, but total joint replacement often ...

Ghost busting

2012-10-25

The fourth installment of the Paranormal Activity films topped the box office last week. Television channel SyFy's hit show Ghost Hunters scares up big ratings, and has spawned copycat series on networks ranging from Biography to Animal Planet. The omnipresence of paranormal entertainment piqued the interest of Paul Brewer, professor of communication, who wondered what makes viewers believe—or disbelieve— what they see on the screen. His resulting study, recently published in the journal Science Communication, examines the influence of media messages about paranormal ...

Measuring Table-Top Accelerators’ State-of-the-Art Beams

2012-10-25

Part Two: Slicing through the electron beam Wim Leemans of Berkeley Lab's Accelerator and Fusion Research Division heads LOASIS, the Laser and Optical Accelerator Systems Integrated Studies, an oasis indeed for students pursuing graduate studies in laser plasma acceleration (LPA). Among the most promising applications of future table-top accelerators are new kinds of light sources, in which their electron beams power free electron lasers. "If our LPA electron bunches had good enough quality for free electron lasers – and were really only femtoseconds long – we should ...

NASA sees Tropical Storm Sandy approaching Jamaica

2012-10-25

NASA satellites are closely monitoring Tropical Storm Sandy in visible and infrared light as it approaches Jamaica. Sandy is now responsible for hurricane and tropical storm warnings and watches from Jamaica to Cuba, the Bahamas and southern Florida. Sandy is expected to become a hurricane before it reaches Jamaica and Cuba. On Oct. 23, 2012 at 1545 UTC (11:45 a.m. EDT), the Moderate Resolution Imaging Spectroradiometer (MODIS) instrument captured a visible image of Tropical Storm Sandy when its center was a couple of hundred miles south of Jamaica. Sandy's clouds filled ...

Challenging Parkinson's dogma

2012-10-25

Scientists may have discovered why the standard treatment for Parkinson's disease is often effective for only a limited period of time. Their research could lead to a better understanding of many brain disorders, from drug addiction to depression, that share certain signaling molecules involved in modulating brain activity. A team led by Bernardo Sabatini, Takeda Professor of Neurobiology at Harvard Medical School, used mouse models to study dopamine neurons in the striatum, a region of the brain involved in both movement and learning. In people, these neurons release ...

Self-affirmation enhances performance, makes us receptive to our mistakes

2012-10-25

Life is about failure as much as it is about success. From the mistakes we make at work or school to our blunders in romantic relationships, we are constantly reminded of how we could be better. By focusing on the important qualities that make us who we are – a process called self-affirmation – we preserve our self-worth in the face of our shortcomings. Self-affirmation has been shown to have powerful effects – research suggests that it can minimize the anxiety, stress, and defensiveness associated with threats to our sense of self while keeping us open to the idea that ...

Results of the ISAR-LEFT MAIN 2 trial presented at TCT 2012

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: